Genome Editing Using CRISPR-Cas Systems: Development and Prospects-Feng Zhang

Поділитися
Вставка
  • Опубліковано 11 гру 2024

КОМЕНТАРІ • 5

  • @davemyers9650
    @davemyers9650 8 років тому +4

    This technology is extremely valuable. Worth 10's of billions. Editas market cap will be 200 billion in 10 years. Much more valuable than any social media company. So several hundred billion market cap is expected.
    This is the most powerful technology on the planet.

    • @wuschelbeutel
      @wuschelbeutel 7 років тому

      if they win in appeals, dont get leapfrogged by a big player or competitor (which may use another protein), dont get blocked by regulatory hurdles, find a suitable delivery mechanism of the system, get reliable and accurate modifications, conduct successful clinical trials, stay afloat with funding..., yeah then maybe

    • @paolotomasello9745
      @paolotomasello9745 7 років тому

      wuschelbeutel santagsltrudecomensoli

  • @cielotempestoso7838
    @cielotempestoso7838 2 роки тому +1

    Sei rozzo ma spieghi facile ! Bravo

    • @Scasco326
      @Scasco326 Рік тому

      Commento assolutamente necessario e apprezzato